Gastroenterology and Hepatology Best Practices

01Purpose and scope

This manual supports the course Gastroenterology and Hepatology. It describes how digestive and liver care is usually organized, from the first symptom review through diagnosis, treatment, monitoring and handoff to the next clinician.
The scope covers general adult gastroenterology and hepatology in outpatient and inpatient settings. That includes evaluation of abdominal pain, bleeding, diarrhea, reflux, inflammatory bowel disease, chronic liver disease, cirrhosis, viral hepatitis, fatty liver disease and liver-related complications, along with the endoscopy and imaging that support them. It also covers the interfaces with surgery, radiology, pathology, pharmacy and primary care. Pediatric practice, transplant surgery technique and detailed interventional procedures are outside the scope of this manual.
This guidance does not replace qualified professional judgment, approved procedures or required authorization. Local protocols, formularies, credentialing rules and privacy requirements control day-to-day work. Where rules depend on jurisdiction, check the current authoritative source, such as your national gastroenterology and hepatology society guidance, your regulator, or your organization's clinical governance policy.

02Core principles

Start with the clinical question. A request for a colonoscopy, a liver ultrasound or a hepatology opinion should state what decision the result will change. Tests that cannot change management add cost, sedation exposure and waiting time without benefit.
Stratify risk before choosing intensity. A patient with new rectal bleeding and a family history of colorectal cancer needs a different pathway from a patient with long-standing functional bowel symptoms and no alarm features. Alarm features such as unexplained weight loss, anemia, melena, hematemesis or new jaundice usually move a case up the queue.
Treat liver disease as a trajectory rather than a single result. One abnormal aminotransferase value rarely settles anything. Trends in bilirubin, albumin, platelets, international normalized ratio and creatinine, together with imaging and the patient's alcohol, medication and metabolic history, give a far better picture.
Make decisions with the patient. Procedures carry specific risks, and treatment for conditions like cirrhosis or inflammatory bowel disease often involves long courses of medication with side effects. Explain options, expected benefit, alternatives and the consequences of doing nothing, then record what the patient agreed to.

03Planning and preparation

Triage referrals on arrival. Sort them by urgency, usually into emergent, urgent and routine categories defined by your service. Confirm the indication, the relevant history, current medications and any prior endoscopy or imaging reports before booking. Missing prior reports are a common reason for repeated procedures.
Reconcile medications early. Anticoagulants, antiplatelet agents, insulin, sodium phosphate or magnesium-containing bowel preparations, iron, and immunosuppressants each raise planning questions. Check with the prescribing clinician before stopping an anticoagulant, and follow local guidance on periprocedural management. Diabetes medication often needs adjustment on the day of a sedated procedure.
Plan bowel preparation and sedation together. Ask about constipation, prior poor preparation, renal disease, heart failure, cirrhosis and diabetes, since these change the choice of preparation and the fluid strategy. Document the sedation plan, airway assessment, American Society of Anesthesiologists physical status if your unit uses it, and the patient's escort arrangements.
Assemble the team and equipment. Endoscopy requires a nurse, a trained endoscopist, a procedural assistant or technician, and in many cases an anesthesia provider. Check that scopes have passed reprocessing and leak testing, that suction and monitoring work, and that specimen containers, labels and the electronic record are ready before the first patient arrives.
Use recognized tools for liver disease. The Child-Pugh score uses bilirubin, albumin, international normalized ratio, ascites and encephalopathy to grade cirrhosis severity. The MELD and MELD-Na scores use bilirubin, international normalized ratio, creatinine and, for MELD-Na, serum sodium, and are used to prioritize transplant listing. FIB-4, calculated from age, aspartate aminotransferase, alanine aminotransferase and platelet count, offers a noninvasive estimate of fibrosis in fatty liver disease and viral hepatitis. Each tool has limits, including reduced accuracy in acute illness, certain ethnic groups and patients with unusual laboratory profiles, so interpret them alongside the clinical picture.

04Recommended workflow

1
: Confirm the indication and urgency from the referral and the first contact. Note red flags such as hemodynamic instability, active bleeding, confusion, fever with abdominal pain, or severe dehydration, and escalate those cases to the on-call team without waiting for a routine slot.
2
: Take a focused history and examination. For liver disease, record alcohol intake, injection drug use, transfusion history, tattoos, travel, family history, metabolic risk factors and all herbal or over-the-counter products. For lower gastrointestinal symptoms, record stool pattern, blood, weight change, travel and antibiotic exposure.
3
: Order the minimum set of tests that answers the question. Common starting points include complete blood count, metabolic panel, liver tests with albumin and international normalized ratio, iron studies, celiac serology when relevant, stool studies for infection, and fecal calprotectin when inflammatory disease is suspected. Add imaging such as ultrasound, computed tomography or magnetic resonance elastography when the result will change the plan.
4
: Review results against the clinical context before deciding on endoscopy or referral. A mildly elevated alanine aminotransferase in a patient with obvious metabolic syndrome points toward a fatty liver workup, while the same number with a recent viral exposure points elsewhere. Record the working diagnosis and the differential.
5
: Obtain consent and complete the procedural safety steps. Confirm the patient's identity, the procedure, the site where applicable, and the sedation plan. Check anticoagulation status, allergies, pregnancy status where relevant, and whether the patient has an advance directive or limits on resuscitation that affect the procedure.
6
: Perform the procedure or visit with a standard approach. During endoscopy, document the extent of examination, bowel preparation quality using your chosen scale, findings with location and size, the number and location of biopsies, and any intervention such as polypectomy, banding or hemostasis. Photograph key findings where your system allows.
7
: Hand off the specimens and results. Label pathology containers at the bedside, record the tracking number, and send requests with the clinical question and relevant history, since pathologists read differently when they know the indication. Assign a named clinician to follow up each pending result.
8
: Close the loop with the patient and the referring clinician. Give verbal and written instructions on diet, medication restart, warning symptoms and the time frame for results. Send a clear report that states the diagnosis, the plan, who owns the next action and when the patient should be reviewed again.

05Quality checks, risk controls and compliance

Build quality checks into each step rather than reviewing only at the end. For endoscopy, these include a documented indication, a pre-procedure safety check, adequacy of bowel preparation, completeness of the examination, and a complete report sent to the referring clinician. For hepatology clinics, check that each patient with cirrhosis has a current plan for surveillance of hepatocellular carcinoma, variceal screening status, vaccination status for hepatitis A and B where indicated, and a review of alcohol use.
Control the high-risk events. Sedation-related hypoxia, post-polypectomy bleeding, perforation, pancreatitis after endoscopic retrograde cholangiopancreatography, and hepatic encephalopathy are the events most likely to cause serious harm. Each has a documented prevention and response pathway. Staff should know where the emergency equipment is and who is responsible for calling for help.
Manage drug dosing in liver impairment. Many drugs are cleared by the liver, and dose adjustments depend on the severity of impairment and on the specific agent. Check the product labeling and a current drug reference before prescribing, and involve pharmacy when the patient has advanced cirrhosis, renal impairment or several interacting medications.
Follow infection control and reprocessing standards. Endoscopes must be cleaned and high-level disinfected or sterilized according to the manufacturer's instructions and your national infection prevention guidance. Records of reprocessing cycles, and any fault or repair, should be kept and traceable to the patient list.
Comply with privacy, consent and controlled substance rules. Records containing HIV, hepatitis, substance use or genetic test results often carry extra protection under local law. Sedation drugs and opioids follow controlled substance handling rules. Requirements differ by jurisdiction, so confirm them with your compliance office.
Be cautious with claims about performance. Quality indicators such as adenoma detection rate, bowel preparation adequacy and 30-day readmission for cirrhosis are useful, but targets should come from your professional society or payer guidance, not from informal assumptions. Do not present a local target as a national benchmark unless it has been formally adopted.

06Collaboration and documentation

Gastroenterology and hepatology work involves many hands. Nurses manage preparation and recovery, technicians support scopes and specimens, anesthesia manages sedation, pharmacists review drug interactions, dietitians plan nutrition for malnourished patients and cirrhosis, and social workers help with alcohol or substance use services and discharge needs. Name the owner of each task at the start of the episode so that nothing depends on memory.
Documentation should let another clinician act without calling you. A procedure report should include indication, sedation, extent, findings, interventions, specimens with tracking numbers, complications, recommendations and follow-up interval. A clinic note should include the working diagnosis, the reasoning for the plan, the monitoring schedule and the patient's stated goals. Avoid copying forward old text without checking that it still applies.
Use multidisciplinary forums for complex cases. Liver tumor boards, inflammatory bowel disease clinics and cirrhosis multidisciplinary reviews bring together hepatology, radiology, surgery, oncology, pathology and palliative care. Record the decision made, the reasons for it and who will communicate it to the patient. The meeting itself does not replace a documented individual plan.
Communicate changes promptly. When pathology returns a result that changes the diagnosis, such as dysplasia or malignancy, the responsible clinician should contact the patient directly and document the conversation. Safety-critical results should follow the local escalation policy, which should specify how long the team has to act.
Make handoffs structured. Use a consistent format at shift change or transfer that covers the active problems, pending results, medications held or restarted, code status, and the specific next action. For patients with hepatic encephalopathy or variceal bleeding, the handoff should include the last neurological assessment and the last hemoglobin.

07Measures and continuous improvement

Track a small number of measures that match the service. Useful examples include time from urgent referral to endoscopy, proportion of procedures with documented indication, bowel preparation adequacy, adenoma detection rate for colonoscopy, unplanned admissions for cirrhosis complications, and the proportion of patients with cirrhosis who receive scheduled surveillance imaging. Define each measure precisely, including numerator, denominator and inclusion rules, before you collect data.
Review measures on a fixed cycle. A monthly run chart for a few indicators is usually more useful than an annual summary, because it shows whether a change is holding. Look at outliers and at specific cases, not just averages. A missed diagnosis of colorectal cancer, a bleeding complication after anticoagulant restart, or a delayed hepatocellular carcinoma scan deserves a structured case review.
Test one change at a time. Small improvement cycles work well here. For example, a clinic might introduce a standard template for cirrhosis visits, audit ten notes after four weeks, and then decide whether to keep, adjust or abandon it. Involve the nurses and administrators who will use the change, since they often see the barriers first.
Watch for trade-offs. A push to raise adenoma detection can increase procedure time or sedation use. Strict surveillance can create a heavy recall burden that patients do not complete. Measures that are easy to count can distract from outcomes that matter more, such as survival, symptom control and quality of life. Balance process measures with patient-reported outcomes where possible.

08Common mistakes and how to prevent them

Relying on a single laboratory value. Normal liver tests do not exclude advanced fibrosis, and a mild abnormality may reflect a serious condition. Check trends, calculate a fibrosis estimate where appropriate and consider imaging or referral when the picture does not fit.
Missing hepatocellular carcinoma surveillance. Patients with cirrhosis are often lost to follow-up after the initial diagnosis. Prevent this by building a recall into the problem list, assigning an owner for the scheduled ultrasound and tracking completion monthly.
Restarting anticoagulants without a plan. Resuming anticoagulation after a procedure without a documented decision about timing has led to avoidable bleeding and thrombosis. Require a written periprocedural plan and confirm the restart date with the patient and the prescribing clinician.
Overlooking alcohol and metabolic causes. Alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease are common, and patients may under-report use. Use a validated screening tool, ask in a nonjudgmental way and document the answer accurately.
Delaying recognition of encephalopathy. Confusion, sleep reversal or asterixis in a patient with cirrhosis should prompt a search for precipitants such as infection, bleeding, constipation, electrolyte disturbance or medication effects. Treat as a potential emergency until proven otherwise.
Inadequate or undocumented bowel preparation. A poor preparation that is not recorded leads to repeat procedures and missed lesions. Record the scale used, the segments affected and the plan for repeat examination, and give preparation instructions in writing with the patient's own medication list.
Losing specimens or results in transit. Pending pathology, stool and culture results often fall through gaps between teams. Use a tracking log, confirm receipt, and assign a follow-up owner for every pending result before the patient leaves.

09Practical checklist

Confirm the indication, urgency and red flags before booking any endoscopy or hepatology review.
Reconcile all medications, including anticoagulants, antiplatelet agents, diabetes drugs and supplements, and document the periprocedural plan.
Review prior endoscopy, imaging and pathology reports and note any gaps.
Complete consent, sedation assessment, airway review and escort arrangements on the day of the procedure.
Check that equipment has been reprocessed, tested and is ready before the first patient.
Calculate and record the relevant liver severity or fibrosis tool where indicated, and interpret it in context.
Label specimens at the bedside and record tracking numbers in the procedure report.
Confirm that each cirrhosis patient has current surveillance, vaccination and alcohol review status.
Send a complete report to the referring clinician with a named owner for each pending action.
Review monthly indicators, examine at least one outlier case, and record the change that follows.

10 ★Learning sources

Micro Degree: Gastroenterology and Hepatology
Micro Degree: Healthcare Administration Practice
Micro Degree: Physiotherapy Assistant Operations
Micro Degree: Cardiac Care Support

?Frequently asked questions

How much of this guidance should I apply if my hospital already has its own endoscopy and hepatology protocols?

Use your local protocols as the controlling document and treat this manual as a description of how the work is usually organized. Where the two differ, raise the difference with your clinical governance lead rather than choosing silently. Local rules also reflect staffing, equipment and patient populations that a general manual cannot capture.

Are the liver severity and fibrosis scores reliable enough to make treatment decisions alone?

They are useful for grading and communicating risk, but they do not replace clinical assessment or the judgment of the treating team. Accuracy can fall in acute illness, in patients with unusual laboratory patterns and in some populations, so interpret them alongside the examination and imaging. Decisions about listing, referral or treatment should follow your local pathway and the relevant specialty guidance.

What should I do if a patient wants to proceed with a procedure that I think is not indicated?

Explain the reasoning in plain terms, describe the risks and the expected benefit, and check whether the patient understands the alternatives, including watchful waiting. Document the discussion and the decision, and involve the referring clinician or a senior colleague if disagreement continues. Follow your organization's policy on declining procedures, since requirements differ by setting and jurisdiction.